| Term 
 
        | 5 things of ideal anesthetic |  | Definition 
 
        | 1.  Quick induction/emergence 2.  Good analgesia 3.  Muscle relaxation 4.  Ability to make quick changes 5.  No S/E   *None of them meet this |  | 
        |  | 
        
        | Term 
 
        | 4 stages of anesthesia (general) |  | Definition 
 
        | 1.  Preanesthetic:  calm pre-surgery   2.  Induction:  Inhalation or IV   3.  Maintenance:  Opioids, ketamine, BZD   4.  Reversal |  | 
        |  | 
        
        | Term 
 
        | Target anesthetic related to MAC |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Nitrous Oxide   1.  MAC 2.  Use 3.  ADEs (2) |  | Definition 
 
        | 1.  105%   2.  Induce euphoria   3.  Hypoxia, risk of abuse (never use > 70%) |  | 
        |  | 
        
        | Term 
 
        | Halothane   1.  Why does it have slow onset and termination?   2.  ADEs (2) |  | Definition 
 
        | 1.  High tissue solubility   2.  Arrhythmia; Hepatotoxicity |  | 
        |  | 
        
        | Term 
 
        | Isoflurane   1.  ADE (1)   2.  Good things about it (3) |  | Definition 
 
        | 1.  Airway irritant   2.  Maintains cardiac funciton; less respiratory depression; smooth emergence |  | 
        |  | 
        
        | Term 
 
        | Desflurane   1.  Fast what?   2.  Use   3.  ADE (1) |  | Definition 
 
        | 1.  Onset and termination   2.  Maintain anesthesia   3.  Airway irritant |  | 
        |  | 
        
        | Term 
 
        | Sevoflurane   1.  Use   2.  Good (3)   3.  Bad (1) |  | Definition 
 
        | 1.  Induction   2.  Less pungent (dec laryngospasm); fewer hemodynamic effects; rapid emergence   3.  Produces free fluoride so avoid in kids |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1.  Barbiturates:  potent and rapid, but respiratory issues 2.  Propofol 3.  Ketamine 4.  Opioids 5.  BZDs 6.  NMBs |  | 
        |  | 
        
        | Term 
 
        | Local Anesthetics   1.  ____ block tranmission of nerve impulses   2.  ___ effect on consciousness |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Ester vs Amide Classification   1.  Bupivacaine 2.  Lidocaine 3.  Tetracaine |  | Definition 
 
        | 1.  Amide   2.  Amide   3.  Ester |  | 
        |  | 
        
        | Term 
 
        | 4 most likely causes of allergy |  | Definition 
 
        | 1.  Lidocaine 2.  Mepivacaine 3.  Prilocaine 4.  Sulfites w/ epinephrine |  | 
        |  | 
        
        | Term 
 
        | 2 rapid onset long duration locals |  | Definition 
 
        | 1.  Tetracaine   2.  Bupivacaine |  | 
        |  | 
        
        | Term 
 
        | 2 slower onset shorter duration locals |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Vasopressors with locals   1.  Help what with duration   2.  Prevents systemic what   3.  Helps provide more |  | Definition 
 
        | 1.  Increase   2.  Toxicity   3.  Hemostasis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1.  Ischemic necrosis   2.  Neurotoxicity   3.  Cardiac toxicity   4.  Methemoglobenimia (Tx is methylene blue) |  | 
        |  | 
        
        | Term 
 
        | Best thing to Tx local anesthetic toxicity |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Max Safe Dose (mg/kg)   1.  Bupivicaine   2.  Lidocaine |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Lipid Rescue from Local toxicity resulting in cardiac arrest   1.  Bolus   2.  Infusion rate   3.  What to do if not working |  | Definition 
 
        | 1.  1.5 mL/kg   2.  0.25 mL/kg/min or 15 mL/hr   3.  Repeat bolus or double infusion |  | 
        |  | 
        
        | Term 
 
        | 1.  Nerve block use   2.  Epidural is a combo of what usually |  | Definition 
 
        | 1.  Post surgical pain or rib fracture   2.  Fentanyl and opioid |  | 
        |  | 
        
        | Term 
 
        | Assessment of pain   1.  3 unidimensional   2.  2 Behavioral |  | Definition 
 
        | 1.  Verbal rating scale; Numerical rating scale; Visual analogue scale   2.  Behavior pain scale; Critical care pain observation tool |  | 
        |  | 
        
        | Term 
 
        | Assessment of Sedation   1.  2 Subjective   2.  4 Objective |  | Definition 
 
        | 1.  Ramsey scale; Riker Sedation-Agitation Scale   2.  Heart rate variability; Lower-esophageal contractility; EEG; Bispectral index (BIS)   Usually use one from each category     |  | 
        |  | 
        
        | Term 
 
        | Behavioral Pain Scale   1.  Numbers and trends   2.  3 Categories measured |  | Definition 
 
        | 1.  1-4 with 1 = less and 4 = most   2.  Facial expression; Upper limb; Compliance with ventilation |  | 
        |  | 
        
        | Term 
 
        | Ramsey Scale   1.  what is scale   2.  What is awake   3.  What is asleep |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Riker Sedation-Agitation Scale   1.  Scale   2.  Low, High |  | Definition 
 
        | 1.  1-7   2.  Low = 1:  narousable   High = 1:  dangerous agitation |  | 
        |  | 
        
        | Term 
 
        | 3 Routes of Administration for Analgesics |  | Definition 
 
        | 1.  IV push (creates burden on nursing)   2.  Continuous infusion (may overmedicate)   3.  PCA (pt must be able to perform) |  | 
        |  | 
        
        | Term 
 
        | Fentanyl   1.  How much more potent than morphine   2.  Onset and duration   3.  Bad point |  | Definition 
 
        | 1.  75-100    2.  Rapid and short   3.  Active metabolite |  | 
        |  | 
        
        | Term 
 
        | Morphine   1.  Lipid solubility   2.  Causes realease of what signaling molecule   3.  Duration |  | Definition 
 
        | 1.  Least lipid soluble   2.  Histamine   3.  4-12 hours |  | 
        |  | 
        
        | Term 
 
        | Hydromophone   1.  Potency compared with morphine   2.  Duration   3.  Active metabolites? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 5 Nonopioid classes/drugs |  | Definition 
 
        | 1.  Locals   2.  APAP   3.  COX inhibitors   4.  Antiepileptics   5.  Ketamine |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1.  Propofol 2.  Alpha-agonist 3.  Neuroleptics 4.  Benzos 5.  Other |  | 
        |  | 
        
        | Term 
 
        | Propofol   1.  MOA 2.  Analgesia?  Amnesia? 3.  Duration 4.  What is PRIS? 5.  Need to monitor what? |  | Definition 
 
        | 1.  Enhances GABA and antagonist at NMDA 2.  Little analgesic, but some antegrade amnesia 3.  Ultra-short acting 4.  Propofol Related Infusion Syndrome (PRIS):  Metabolic acidosis, rhabdo, elevated CK, renal failure, myocardial failure, arrhythmias, hyperlipidemia...most likely with prolonged infusion at high dose 5.  TGs...Change tubing every 12 h...1.1 kcal/mL |  | 
        |  | 
        
        | Term 
 
        | Dexmedetomidine    1.  Good point 2.  Labeled for how much use? 3.  S/E 4.  Duration of action |  | Definition 
 
        | 1.  Easy arousability 2.  < 24 hours 3.  Hypotension and brady 4.  2-6 hours |  | 
        |  | 
        
        | Term 
 
        | Benzodiazepines   1.  What type of amnesia   2.  ____ sparing effect b/c of dec anticipatory effects |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Midazolam   1.  Half-life   2.  Duration |  | Definition 
 
        | 1.  Very short   2.  2-6 hours |  | 
        |  | 
        
        | Term 
 
        | Lorazepam   1.  Potency of BZDs   2.  Active metabolite?   3.  Solvent |  | Definition 
 
        | 1.  Most potent   2.  None   3.  Propylene glycol so as low as 1 mg/kg can cause toxicity |  | 
        |  | 
        
        | Term 
 
        | Diazepam   1.  Duration   2.  How often is it used |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1.  Neuroleptics   2.  Etomidate (procedural)   3.  Ketamine   4.  Barbiturates   5.  Benadryl |  | 
        |  | 
        
        | Term 
 
        | 5 Indications for NMB use |  | Definition 
 
        | 1.  ALI/ARDS   2.  Status asthmaticus   3.  Elevated ICP   4.  Tetanus   5.  Therapeutic hypothermia  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1.  Decrease O2 consumption   2.  Facilitates mechaincal ventilation   3.  Decreases muscle spasms   4.  Avoids barotrauma |  | 
        |  | 
        
        | Term 
 
        | Aminosteroidal Nondepolarizing NMBs (5) |  | Definition 
 
        | 1.  Pancuronium 2.  Pipecuronium 3.  Vecuronium 4.  Rocuronium 5.  Rapacuronium  |  | 
        |  | 
        
        | Term 
 
        | Benzylisoquinolinium Nondepolarizing NMBs (5) |  | Definition 
 
        | 1.  Cisatracurium   2.  Atracurium   3.  D-tubocurarine   4.  Doxacurium   5.  Mivacurium  |  | 
        |  | 
        
        | Term 
 
        | Succinylcholine   1.  Only for what type of procedures   2.  Onset/Duration   3.  ADE |  | Definition 
 
        | 1.  Short, RSI   2.  Fast onset, short duration   3.  Hyperkalemia |  | 
        |  | 
        
        | Term 
 
        | Pancuronium   1.  Class   2.  Duration of action   3.  ADEs (2)   4.  Avoid in what (2) |  | Definition 
 
        | 1.  Aminosteroidal   2.  Long (60-90 min)   3.  Vagolytic; Histamine release   4.  Renal and hepatic failure |  | 
        |  | 
        
        | Term 
 
        | Vecuronium   1.  Class   2.  Length   3.  Good difference from pancuronium   4.  Avoid in |  | Definition 
 
        | 1.  Aminosteroidal   2.  Intermediate   3.  Not a vagolytic   4.  Avoid in renal and hepatic failure  |  | 
        |  | 
        
        | Term 
 
        | Rocuronium   1.  Class   2.  Duration   3.  Metabolite? |  | Definition 
 
        | 1.  Aminosteroidal   2.  Intermediate (30 min)   3.  Active metabolite |  | 
        |  | 
        
        | Term 
 
        | Atracurium    1.  Class   2.  Special elimination   3.  Duration |  | Definition 
 
        | 1.  Benzylisoquinoliniums   2.  Hoffman (avoids renal and hepatic issues)   3.  Intermediate |  | 
        |  | 
        
        | Term 
 
        | Cisatracurium   1.  Class   2.  Duration   3.  Advantage over atracurium   4.  Elimination |  | Definition 
 
        | 1.  Benzylisoquinoliniums   2.  Intermediate   3.  Less mast cell degranulation   4.  Hofmann elimination |  | 
        |  | 
        
        | Term 
 
        | 3 monitoring parameters with NMBs |  | Definition 
 
        | 1.  Observation (lack of movement)   2.  Ventilator software (can detect overbreathing)   3.  Peripheral nerve stimulation (Train of Four [goal is 2-3]) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1.  Analgesia   2.  Sedation (as deep as possible)   3.  Eye care to prevent eye drying damage |  | 
        |  | 
        
        | Term 
 
        | Complications of NMBs (4) |  | Definition 
 
        | 1.  Prolonged recovery so do not stop sedation and analgesia at same time as NMB   2.  Acute quadriplegic myopathy:  with long use, nutritional def, DDI   3.  Myositis ossificans:  Connective tissue; fibrobalsts; osteoblasts; supportive care and PT   4.  Tachyphylaxis |  | 
        |  | 
        
        | Term 
 
        | 6 Keys to Safe Storage of NMBs |  | Definition 
 
        | 1.  High-alert med list 2.  Distinctive labeling 3.  Auxillary labels 4.  Avoid similar names 5.  Store separately  6.  Limit availability  |  | 
        |  | 
        
        | Term 
 
        | 6 steps for safe use of NMBs |  | Definition 
 
        | 1.  Only use as last option2.  Never "prn agitation"
 3.  D/C once moved to floor 4.  Never call "muscle relaxants"-->Paralyzing agents 5.  Use lowest dose possible 6.  Focused educaiton (providers on complications & risk)  |  | 
        |  | 
        
        | Term 
 
        | Assessing Pain goals for    1.  Behavioral Pain Scale (BPS)   2.  Critical Care Pain Observation (CCPO) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Assessing Sedation goals   1.  Ramsey or Riker Sedation/Agitation Scale   |  | Definition 
 
        | 1.  Ramsey:  2-3   2.  Riker:  3-4 |  | 
        |  | 
        
        | Term 
 
        | Atropine    1.  Dose   2.  When to use   3.  When not to use |  | Definition 
 
        | 1.  0.5 mg IVP up to 3 mg   2.  Brady   3.  Cardiac ischemia, heart transplant |  | 
        |  | 
        
        | Term 
 
        | Dopamine   1.  Use   2.  Infusion rate   3.  Must maintain |  | Definition 
 
        | 1.  Bradycardia   2.  2-10 mcg/kg/min   3.  Maintain intravascular volume |  | 
        |  | 
        
        | Term 
 
        | Isoproterenol   1.  Start   2.  Used to tx |  | Definition 
 
        | 1.  2-10 mcg/kg/min   2.  Brady |  | 
        |  | 
        
        | Term 
 
        | Adenosine   1.  Dose   2.  Contraindicated in   3.  When can you use |  | Definition 
 
        | 1.  6, 12, 12 followed by 20 mg flush fast push   2.  WPW   3.  Regular and monomorphic tachycardia (particularly narrow QRS)   |  | 
        |  | 
        
        | Term 
 
        | 3 antiarrhythmics for wide QRS |  | Definition 
 
        | 1.  Procanamide   2.  Amiodarone   3.  Sotalol |  | 
        |  | 
        
        | Term 
 
        | Pulseless V Tach or V fib   1.  Order of stuff |  | Definition 
 
        | 1.  Shock 2.  CPR X 2 min 3.  Shock 4.  Epi (1 mg IVP Q3-5 min) 5.  Shock 6.  Amiodarone (300 mg load) 7. Shock 8.  Epi 9.  Amiodarone (150 mg bolus):  1 mg/min drip if converts |  | 
        |  | 
        
        | Term 
 
        | Vasopressin   1.  Dose   2.  When to use     |  | Definition 
 
        | 1.  40 U IVP   2. Longer half-life version of Epi so use in a pt who responds to epi and then decompensates |  | 
        |  | 
        
        | Term 
 
        | Pulseless Electrical Activity/Asystole   1.  Looks like what?   2.  Treatment algorithm |  | Definition 
 
        | 1.  Sinus brady but w/o pulse   2.  CPR X2 min and 1 mg epi Q3-5 min If shockable, switch to other route |  | 
        |  | 
        
        | Term 
 
        | 4 Reversible H's of arrest |  | Definition 
 
        | 1.  Hypovolemia   2.  Hypoxia   3.  Hydrogen ions   4.  Hypo/hyperkalemia |  | 
        |  | 
        
        | Term 
 
        | 4 reversible T's of arrest |  | Definition 
 
        | 1.  Tension pneumothorax   2.  Tamponade   3.  Toxins   4.  Thrombosis |  | 
        |  | 
        
        | Term 
 
        | What lab can you not get with IO |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1.  Naloxone   2.  Atropine   3.  Vasopressin   4.  Epi   5.  Lidocaine |  | 
        |  | 
        
        | Term 
 
        | Diagnostic PH   1. Pulmonary arterial pressure > |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1.  Idiopathic 2.  Heritable 3.  Drugs and Toxin induced 4.  Persistant HTN of newborn |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pulmonary veno-occlusive disease and or pulmonary capillary hemangiomatosis |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Lung disease/hypoxia...basically anything reducing oxygen |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Chronic thromoboembolic pulmonary HTN |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | PH with unclear or multifactorial mechaisms |  | 
        |  | 
        
        | Term 
 
        | Measure labs how often for PH |  | Definition 
 
        | Clinical assessment, WHO-FC, ECG, 6 min walk test, BNP at baseline and then every 3-6 months |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1.  Exercise 2.  Support group 3.  Don't get prego 4.  Travel may need O2 5.  Psychosocial support 6.  Influenza adn pneumovax |  | 
        |  | 
        
        | Term 
 
        | Supportive therapy PAH (4) |  | Definition 
 
        | 1.  Oral anticoagulants   2.  Diuretics   3.  Oxygen   4.  Digoxin |  | 
        |  | 
        
        | Term 
 
        | Epoprostenol   1.  How long stable   2.  Initial/Optimal dose   3.  What hapens if suddenly stopped |  | Definition 
 
        | 1.  8-12 hrs at room temp, must give by continious infusion pump   2.  2-4 ng/kg/min; 20-40 ng/kg/min   3.  Rebound PH and death   *$33,153 |  | 
        |  | 
        
        | Term 
 
        | Iloprost   1.  Dosing route (2)   2.  Dose schedule     |  | Definition 
 
        | 1.  Aerosol, intravenous   2.  2.5-5 mcg/inhalation 6-9 times daily   *$92,146 |  | 
        |  | 
        
        | Term 
 
        | Treprostinil   1.  Stable how long   2.  Routes (4)   3.  Dose     |  | Definition 
 
        | 1.  48 hrs room temp   2.  SC (preferred), IV, Inhaled, oral   3.  1-2 ng/kg/min; Optimal 20-80 ng/kg/min   $97.615 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | HA, jaw pain, flushing, nausea, diarrhea, skin rash, musculoskeletal pain |  | 
        |  | 
        
        | Term 
 
        | Bosentan   1.  Class   2.  Dose   3.  Monitoring   4.  Decreases efficacy of what |  | Definition 
 
        | 1.  Entothelin receptor antagonists   2. 62.5 mg BID for 4 wks, then increase to 125 mg BID   3.  LFTs monthly and HCt Q3 months   4.  Oral contraceptives   *$55,890 |  | 
        |  | 
        
        | Term 
 
        | Ambrisentan   1.  Category   2.  Dose   3.  Monitoring   4.  Decreases efficacy of |  | Definition 
 
        | 1.  Endothelin receptor antagonists   2.  5 mg daily, if tolerated inc 10 mg daily   3.  LFTs monthly, Hct Q3M   4.  OC   *$56,736 |  | 
        |  | 
        
        | Term 
 
        | PDE inhibitor approved for PH |  | Definition 
 
        | Sildenafil   20 mg TID   *12,761 |  | 
        |  |